Detalles de la búsqueda
1.
Increased Subthalamic Nucleus Deep Brain Stimulation Amplitude Impairs Inhibitory Control of Eye Movements in Parkinson's Disease.
Neuromodulation
; 25(6): 866-876, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-34139037
2.
The effect of STN DBS on modulating brain oscillations: consequences for motor and cognitive behavior.
Exp Brain Res
; 238(7-8): 1659-1676, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32494849
3.
Bilateral subthalamic nucleus deep brain stimulation increases fixational saccades during movement preparation: evidence for impaired preparatory set.
Exp Brain Res
; 237(11): 2841-2851, 2019 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-31455999
4.
Subthalamic Physiology in Genetic Subtypes of Parkinson's Disease.
Mov Disord
; 38(6): 1113-1114, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37475610
5.
Bilateral deep brain stimulation of the subthalamic nucleus increases pointing error during memory-guided sequential reaching.
Exp Brain Res
; 236(4): 1053-1065, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29427240
6.
The effects of unilateral versus bilateral subthalamic nucleus deep brain stimulation on prosaccades and antisaccades in Parkinson's disease.
Exp Brain Res
; 235(2): 615-626, 2017 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27844097
7.
Effects of 2 Years of Exercise on Gait Impairment in People With Parkinson Disease: The PRET-PD Randomized Trial.
J Neurol Phys Ther
; 41(1): 21-30, 2017 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-27977518
8.
Progressive resistance exercise restores some properties of the triphasic EMG pattern and improves bradykinesia: the PRET-PD randomized clinical trial.
J Neurophysiol
; 116(5): 2298-2311, 2016 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27582297
9.
Exercise improves cognition in Parkinson's disease: The PRET-PD randomized, clinical trial.
Mov Disord
; 30(12): 1657-63, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26148003
10.
Endurance exercise reduces cortisol in Parkinson's disease with mild cognitive impairment.
Mov Disord
; 34(8): 1238-1239, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31107979
11.
Benefits of subthalamic nucleus deep brain stimulation on visually-guided saccades depend on stimulation side and classic paradigm in Parkinson's disease.
Clin Neurophysiol
; 162: 41-52, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38555666
12.
A two-year randomized controlled trial of progressive resistance exercise for Parkinson's disease.
Mov Disord
; 28(9): 1230-40, 2013 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23536417
13.
Hyporesponsiveness to social and nonsocial sensory stimuli in children with autism, children with developmental delays, and typically developing children.
Dev Psychopathol
; 25(2): 307-20, 2013 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-23627946
14.
Cross-education in people with Parkinson's disease, a short-term randomized controlled trial.
J Bodyw Mov Ther
; 35: 114-120, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37330755
15.
The Effects of Subthalamic Nucleus Deep Brain Stimulation and Retention Delay on Memory-Guided Reaching Performance in People with Parkinson's Disease.
J Parkinsons Dis
; 13(6): 917-935, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37522216
16.
Medication only improves limb movements while deep brain stimulation improves eye and limb movements during visually-guided reaching in Parkinson's disease.
Front Hum Neurosci
; 17: 1224611, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37850040
17.
Encoding type, medication, and deep brain stimulation differentially affect memory-guided sequential reaching movements in Parkinson's disease.
Front Neurol
; 13: 980935, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36324383
18.
Medication adversely impacts visually-guided eye movements in Parkinson's disease.
Clin Neurophysiol
; 143: 145-153, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35995722
19.
Psychometric validation of the Sensory Experiences Questionnaire.
Am J Occup Ther
; 65(2): 207-10, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-21476368
20.
Subthalamic Peak Beta Ratio Is Asymmetric in Glucocerebrosidase Mutation Carriers With Parkinson's Disease: A Pilot Study.
Front Neurol
; 12: 723476, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34659089